(VRTX) |
| 0 (0%) 07-13 19:56 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 533.67 |
| Resistance 1: | 495.52 |
| Pivot price: | 494.45 |
| Support 1: | 433.80 |
| Support 2: | 360.92 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 16.840 |
| Book Value | 76.180 |
| PEG Ratio | 1.85 |
| Gross Profit | 26.201 |
| Profit Margin (%) | 35.51 |
| Operating Margin (%) | 38.13 |
| Return on Assets (ttm) | 12.1 |
| Return on Equity (ttm) | 24.2 |
Company news
Mon, 13 Jul 2026
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors - Yahoo Finance Singapore
Mon, 13 Jul 2026
VRTX Maintained by UBS -- Price Target Raised to $585 - GuruFocus
Mon, 13 Jul 2026
VRTX Maintained by Truist Securities -- Price Target Raised to $560 - GuruFocus
Mon, 13 Jul 2026
Wells Fargo Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $550 - 富途牛牛
Mon, 13 Jul 2026
What to Expect From Vertex Pharmaceuticals' Next Quarterly Earnings Report - Yahoo Finance
Mon, 13 Jul 2026
Vertex Pharmaceuticals (VRTX) Announces $10B Acquisition of Crinetics Pharmaceuticals - GuruFocus
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
